Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bluebird-Bio
Company Monitoring Page for Bluebird-Bio
latest headlines for company on cafepharma
Bluebird Bio submits BLA for sickle cell disease gene therapy
Biopharma Reporter
Mon, 04/24/23 - 11:39 am
Tags:
Bluebird Bio
,
sickle cell disease
,
lovo-cel
,
FDA
Bluebird to miss Q1 deadline for lovo-cel filing, shares sliced
Endpoints
Wed, 03/29/23 - 04:04 pm
Tags:
Bluebird Bio
,
sickle cell disease
,
gene therapy
,
FDA
,
lovo-cel
Medicaid, with planned payment pilot, girds for influx of pricey gene therapies
BioPharma Dive
Tue, 02/21/23 - 04:37 pm
Tags:
Medicaid
,
sickle cell disease
,
gene therapies
,
Bluebird Bio
,
Vertex Pharmaceuticals
,
CRISPR Therapeutics
Bluebird hopes to raise upwards of $100M by selling shares
Endpoints
Wed, 01/18/23 - 12:08 pm
Tags:
Bluebird Bio
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
Motley Fool
Wed, 01/18/23 - 09:50 am
Tags:
Moderna Therapeutics
,
RSV
,
Bluebird Bio
,
NASDAQ
FDA Lifts Partial Clinical Hold On Bluebird Bio's Sickle Cell Disease Studies
NASDAQ
Mon, 12/19/22 - 10:59 am
Tags:
Bluebird Bio
,
FDA
,
clinical trials
,
lovo-cel
,
sickle cell disease
J&J’s next myeloma drug, Argenx’s second act and a new question for Bluebird: 3 ASH takeaways
BioPharma Dive
Mon, 12/12/22 - 10:56 pm
Tags:
ASH 2022
,
JNJ
,
talquetamab
,
Multiple Myeloma
,
Argenx
,
Bluebird Bio
,
Vyvgart
,
ITP
ASH: Despite partial clinical hold, bluebird's sickle cell gene therapy remains on track
Fierce Pharma
Sun, 12/11/22 - 01:34 pm
Tags:
Bluebird Bio
,
ASH 2022
,
Zynteglo
,
sickle cell disease
,
gene therapy
,
lovo-cel
Bluebird Bio Sells Priority Review Voucher For $102M, Strengthening Its Financial Position
Benzinga
Wed, 11/30/22 - 10:47 am
Tags:
Bluebird Bio
,
priority review vouchers
,
FDA
,
Argenx
ASH preview – waiting for Editas
EP Vantage
Wed, 11/9/22 - 10:40 am
Tags:
ASH 2022
,
sickle cell disease
,
Bluebird Bio
,
Sangamo BioSciences
,
Novartis
,
Editas Medicine
,
gene therapy
,
Vertex Pharmaceuticals
,
Sanofi
Cost watchdog ICER backs multimillion-dollar price tags for BioMarin, CSL hemophilia gene therapies
Fierce Pharma
Thu, 11/3/22 - 11:02 am
Tags:
ICER
,
drug pricing
,
gene therapy
,
Biomarin
,
CSL
,
Bluebird Bio
,
hemophilia
Bluebird wins FDA approval of gene therapy for rare brain disorder
BioPharma Dive
Sun, 09/18/22 - 10:23 pm
Tags:
Bluebird Bio
,
gene therapy
,
cALD
,
Skysona
,
FDA
Go or no go? Bristol’s Tyk2 test
EP Vantage
Wed, 08/31/22 - 10:15 am
Tags:
FDA
,
Bristol Myers Squibb
,
deucravacitinib
,
Amylyx Pharmaceuticals
,
ALS
,
AMX0035
,
Ferring Pharmaceuticals
,
microbiome
,
RBX2660
,
Revance Therapeutics
,
Bluebird Bio
,
Spectrum Pharmaceuticals
,
JNJ
,
Oncopeptides
bluebird bio Scores First U.S. Approval for Lentiviral Vector Gene Therapy
BioSpace
Wed, 08/17/22 - 11:34 pm
Tags:
Bluebird Bio
,
FDA
,
gene therapy
,
beta thalassemia
,
Zynteglo
,
beti-cel
Go or no go? J&J’s bispecific FDA first
EP Vantage
Thu, 07/28/22 - 11:04 am
Tags:
JNJ
,
Amicus Therapeutics
,
Acadia Pharma
,
Bluebird Bio
,
FDA
FDA Has Ways to Go to Keep Pace with 2020/21 Approvals
BioSpace
Wed, 07/6/22 - 11:05 am
Tags:
FDA
,
drug approvals
,
Amicus
,
Bluebird Bio
,
Bristol Myers Squibb
,
Eli Lilly
,
Marinus Pharma
,
Amylyx
,
Novartis
bluebird bio Soars as FDA Adcom Recommends Second Gene Therapy
BioSpace
Sun, 06/12/22 - 08:30 pm
Tags:
Bluebird Bio
,
FDA
,
lentiviral vectors
,
beti-cel
FDA panel backs Bluebird gene therapy despite safety risks
BioPharma Dive
Fri, 06/10/22 - 10:56 am
Tags:
Bluebird Bio
,
FDA
,
eli-cel
,
cALD
Bluebird bio’s future in balance as FDA weighs gene therapy approvals
BioPharma Dive
Thu, 06/9/22 - 10:32 am
Tags:
Bluebird Bio
,
gene therapy
bluebird bio Blazes Trail for Lentiviral Vectors at Upcoming FDA Meeting
BioSpace
Tue, 06/7/22 - 11:57 pm
Tags:
Bluebird Bio
,
lentiviral vectors
,
FDA
,
cell therapy
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.